Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Dow Jones Today: Stocks Open Mixed as Fed Meeting Begins; Trump Approves Nvidia H200 Chip Sales to China
10:30am, Tuesday, 09'th Dec 2025
Major stock indexes were mixed Tuesday after President Donald Trump approved limited sales of Nvidia H200 AI chips to China and the two-day Federal Reserve meeting on interest rates began.
CVS Health updated its 2025 guidance again, and the stock is rallying
10:21am, Tuesday, 09'th Dec 2025
CVS Health's stock was up about 4% at the market open on Tuesday after the company boosted its revenue and profit guidance for the year and detailed its full-year expectations for 2026.
CVS Health lifts full-year guidance during investor event
10:17am, Tuesday, 09'th Dec 2025
CVS Health Corp (NYSE:CVS) shares moved higher on Tuesday after raising its full-year 2025 financial guidance during its Investor Day event, reflecting stronger performance across its health care busi
CVS Health Outlines New Revenue Targets, AI Upgrades At Investor Day
10:12am, Tuesday, 09'th Dec 2025
CVS Health Inc. (NYSE: CVS) outlined its future growth plans at its investor day on Tuesday.
Cramer's Mad Dash: CVS Health
09:48am, Tuesday, 09'th Dec 2025
CNBC's Jim Cramer delivers his daily Mad Dash.
Stock Futures Quiet with Nvidia, Chip Stocks in Focus
09:12am, Tuesday, 09'th Dec 2025
Stock futures are muted this morning, with Nvidia (NVDA) in focus after getting clearance to sell AI chips in China
CVS Health Boosts Full-Year 2025 Guidance, Sees Profit Growth in 2026
07:39am, Tuesday, 09'th Dec 2025
CVS Health raised its full-year outlook and guided for profit growth next year.
CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.
07:35am, Tuesday, 09'th Dec 2025
The healthcare company says it expects to post a narrower per-share loss in 2025.
CVS forecasts 2026 profit above estimates on strong performance
06:31am, Tuesday, 09'th Dec 2025
CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
Outlines strategy to deliver best-in-class execution, transform consumer experiences, be the partner of choice, and harness unique enterprise capabilities Updates 2025 full-year financial guidance;
CVS Health Corporation $CVS Stock Position Boosted by Callodine Capital Management LP
04:52am, Sunday, 07'th Dec 2025
Callodine Capital Management LP grew its stake in shares of CVS Health Corporation (NYSE: CVS) by 78.6% in the undefined quarter, according to its most recent disclosure with the SEC. The institutiona
CVS: FY 2026 Margin Recovery, Well Covered Dividends, And Cheap Valuations
01:38am, Saturday, 06'th Dec 2025
CVS remains a great Buy here, driven by the raised FY2025 adj EPS guidance and the robust outperformance against its healthcare peers despite the industrywide headwinds. Margin recovery is expected to
CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States
09:00am, Friday, 05'th Dec 2025
New report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities WOONSOCKET, R.I. , Dec. 5, 2025 /PRNewswire/ -- CVS Health® (NYSE: CV
Aetna expands initiatives to simplify experiences for health care professionals and patients
08:00am, Thursday, 04'th Dec 2025
Bundling medical procedures and pharmaceutical medications into one prior authorization Implementing end-to-end generative AI capabilities into Aetna Health app HARTFORD, Conn. , Dec. 4, 2025 /PRNewsw
First Look: Insurers, Auto Rules, AI and Fed Jitters
07:38am, Thursday, 04'th Dec 2025
Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
